Nimotuzumab

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor|Pharmacologic Substance

**Definition:** A humanized monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Nimotuzumab binds to and inhibits EGFR, resulting in growth inhibition of tumor cells that overexpress EGFR. This agent may act synergistically with radiation therapy.

**Synonyms:** - H-R3 - NIMOTUZUMAB - Thera-CIM-hr3 - TheraCim hR3 - Theraloc - Theraloc - hR3 - nimotuzumab